{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:08:10Z","timestamp":1759410490401},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/inf.0b013e31825e6cd6","type":"journal-article","created":{"date-parts":[[2012,7,14]],"date-time":"2012-07-14T10:01:39Z","timestamp":1342260099000},"page":"848-858","source":"Crossref","is-referenced-by-count":13,"title":["Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children 6 Months to <9 Years of Age"],"prefix":"10.1097","volume":"31","author":[{"given":"Joanne M.","family":"Langley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Reich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naresh","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc H.","family":"Lebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartley","family":"Garfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Madan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-16-20210202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2458-8-61","article-title":"Social contact networks for the spread of pandemic influenza in children and teenagers.","volume":"8","author":"Glass","year":"2008","journal-title":"BMC Public Health"},{"issue":"RR-8","key":"R3-16-20210202","first-page":"1","article-title":"Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.","volume":"58","author":"Fiore","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"R5-16-20210202","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2009.1536","article-title":"Critically ill patients with 2009 influenza A(H1N1) in Mexico.","volume":"302","author":"Dominguez-Cherit","year":"2009","journal-title":"JAMA"},{"key":"R11-16-20210202","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00044011-200222110-00004","article-title":"Ten years of experience with the trivalent split-influenza vaccine, Fluarix.","volume":"22","author":"Hehme","year":"2002","journal-title":"Clin Drug Invest"},{"key":"R12-16-20210202","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pone.0001665","article-title":"Broad clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine.","volume":"3","author":"Leroux-Roels","year":"2008","journal-title":"PLoS One"},{"key":"R13-16-20210202","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.vaccine.2010.12.125","article-title":"Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naive ferrets.","volume":"29","author":"Baras","year":"2011","journal-title":"Vaccine"},{"key":"R14-16-20210202","first-page":"493","article-title":"A simple method of calculating fifty percent end point.","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"R18-16-20210202","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1056\/NEJMoa0908535","article-title":"A novel influenza A (H1N1) vaccine in various age groups.","volume":"361","author":"Zhu","year":"2009","journal-title":"N Engl J Med"},{"key":"R20-16-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(09)62026-2","article-title":"Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.","volume":"375","author":"Plennevaux","year":"2010","journal-title":"Lancet"},{"key":"R21-16-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)62003-1","article-title":"Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.","volume":"375","author":"Liang","year":"2010","journal-title":"Lancet"},{"key":"R23-16-20210202","doi-asserted-by":"crossref","first-page":"c2649","DOI":"10.1136\/bmj.c2649","article-title":"Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.","volume":"340","author":"Waddington","year":"2010","journal-title":"BMJ"},{"key":"R24-16-20210202","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/INF.0b013e31819d6394","article-title":"Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R25-16-20210202","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/382883","article-title":"Inactivated influenza virus vaccines in children.","volume":"38","author":"Ruben","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R26-16-20210202","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00006454-200108000-00004","article-title":"Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience.","volume":"20","author":"Neuzil","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R28-16-20210202","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1750-2659.2010.00146.x","article-title":"Protective effect of single-dose adjuvanted pandemic influenza vaccine in children.","volume":"4","author":"Van Buynder","year":"2010","journal-title":"Influenza Other Respi Viruses"},{"key":"R29-16-20210202","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1016\/j.vaccine.2009.01.040","article-title":"Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.","volume":"27","author":"Schwarz","year":"2009","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e31825e6cd6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:31:38Z","timestamp":1620955898000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201208000-00016"}},"subtitle":["Safety and Immunogenicity"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31825e6cd6","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}